Jilekan (7686-TW) is expected to list on the Over-the-Counter (OTC) market on August 31. Chairman Tseng Yu-chieh stated today that Jilekan is expanding its clinical applications based on two core technologies, LipoShell (soft tissue filling platform) and HeliBarb (soft tissue support platform).